Breast Cancer Therapy
Studies from Institute of Cancer Research in the area of breast cancer therapy described
Published in Women's Health Law Weekly, March 11th, 2007
Data detailed in "Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy" have been presented. According to recent research from London, the United Kingdom, "We analysed the molecular genetic profiles of breast cancer samples before and after neoadjuvant chemotherapy with combination doxorubicin and cyclophosphamide (AC). DNA was obtained from microdissected frozen breast core biopsies from 44 patients before chemotherapy."
"Additional samples were obtained before the second course of chemotherapy (D21) and after the completion of the treatment (surgical specimens) in 17 and 21 patients, respectively....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Breast Cancer
Philadelphia Hormone Therapy Trial Completed - Medicare and Medicaid
Midwives Applaud Introduction of Medicare Equity Legislation - Adverse Drug Reactions
Scientists at MDS Pharma Services publish new data on adverse drug reactions - Aggression
New aggression study results from University of Rochester described - Aging
Research from Medical School reveals new findings on aging - Aging
Wake Forest University, Center on Aging publishes research in aging - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
